Skip to content

Insider · CIK 0001443340

Bancel Stephane

ceoofficerdirector

Files at MRNA (Moderna, Inc.). First filing Mar 4, 2025, latest Mar 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$5.0M bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
50ModeratebuyMRNA
Moderna, Inc.
$5.0M160,314+2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2025MRNA
Moderna, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+102,821$31.04$3.2M9,153,193Mar 4, 2025
Mar 3, 2025MRNA
Moderna, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+57,493$31.53$1.8M9,210,686Mar 4, 2025
Mar 1, 2025MRNA
Moderna, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+357,065$0.00$0357,065Mar 3, 2025
Feb 12, 2025MRNA
Moderna, Inc.
AGrant or award
Common Stock
+13,233$0.00$05,500,297Feb 14, 2025
Feb 12, 2025MRNA
Moderna, Inc.
FTax withholding
Common Stock
-6,400$30.93$198k5,493,897Feb 14, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bancel Stephane: insider trades and track record | InsiderTell